Your browser doesn't support javascript.
loading
Case report: multifocal chronic paracoccidioidomycosis in an adult / Informe de caso: paracoccidioidomicosis crónica multifocal del adulto
Zapata, Karen; Villanueva, Janeth; Arrunátegui, Adriana; López, Juana Gabriela.
  • Zapata, Karen; Universidad del Valle. Faculty of Health. School of Medicine. Cali. CO
  • Villanueva, Janeth; Universidad del Valle. Faculty of Health. School of Medicine. Cali. CO
  • Arrunátegui, Adriana; Universidad del Valle. Faculty of Health. School of Medicine. Cali. CO
  • López, Juana Gabriela; Universidad del Valle. Faculty of Health. School of Medicine. Cali. CO
Colomb. med ; 42(2): 228-232, abr.-jun. 2011. ilus
Article in English | LILACS | ID: lil-592459
ABSTRACT
Paracoccidioides brasiliensis is the ethiological agent of one of the most prevalent systemic mycosis in Latin America, where around ten-million individuals are affected. Brazil has the highest incidence but in Venezuela, Colombia, Ecuador, and Argentina cases have also been reported. We describe a 56-year-old male with a one year history of lip, oral mucosa, and lung lesions. Granulomas and multinucleated giant cells were observed in histopathological evaluation with haematoxilyn-eosin stain. Mycologic studies (KOH and Gomori Grocott stain) showed blastoconidias with multiple budding. Serologic tests for paracoccidioidine were reactive. A diagnosis of chronic multifocal paracoccidioidomycosis was made. Initially, amphotericin B 0.7 mg/kg per day was started for fifteen days and consecutively itraconazole (400 mg/day) was administered orally with improvement of skin and lung lesions; however, an important residual fibrosis was observed. The patient was lost to follow up. We highlight the importance of an early diagnosis and adequate treatment to decrease sequelae in patient quality of life.
RESUMEN
Paracoccidioides brasiliensis es el agente causal de una de las micosis sistémicas con mayor prevalencia en Latinoamérica. Existen alrededor de 10 millones de afectados y la mayor incidencia se presenta en Brasil y se han observado casos en Venezuela, Colombia, Ecuador y Argentina. Se presenta el caso de un hombre de 56 años con lesiones de un año de evolución en labios, mucosa oral y pulmón. El estudio histopatológico con hematoxilina-eosina informó la presencia de granulomas y células gigantes multinucleadas. Los estudios micológicos (KOH y tinción de Gomori Grocott) mostraron blastoconidias con gemación múltiple. Las pruebas serológicas para paracoccidioidina fueron reactivas. Se diagnosticó un caso de paracoccidioidomicosis multifocal crónica y se inició tratamiento anfotericina B 0.7 mg/kg/día durante 15 días, luego itraconazol 400 mg diarios. Las lesiones cutáneas y pulmonares mejoraron; sin embargo, presentaba una fibrosis residual importante en la región oral y no continuó el seguimiento. Se resalta la importancia de realizar un diagnóstico temprano y disminuir las posibles secuelas que van a repercutir directamente sobre la calidad de vida del paciente.
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Paracoccidioidomycosis / Amphotericin B / Itraconazole / Diagnosis Type of study: Diagnostic study / Risk factors / Screening study Limits: Humans / Male Language: English Journal: Colomb. med Journal subject: Medicine Year: 2011 Type: Article Affiliation country: Colombia Institution/Affiliation country: Universidad del Valle/CO

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Paracoccidioidomycosis / Amphotericin B / Itraconazole / Diagnosis Type of study: Diagnostic study / Risk factors / Screening study Limits: Humans / Male Language: English Journal: Colomb. med Journal subject: Medicine Year: 2011 Type: Article Affiliation country: Colombia Institution/Affiliation country: Universidad del Valle/CO